Product Name:4-chloroquinazoline

IUPAC Name:4-chloroquinazoline

CAS:5190-68-1
Molecular Formula:C8H5ClN2
Purity:97%
Catalog Number:CM114974
Molecular Weight:164.59

Packing Unit Available Stock Price($) Quantity
CM114974-5g in stock Ǹħ
CM114974-10g in stock ŽǎǸ
CM114974-25g in stock ǎřij

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:5190-68-1
Molecular Formula:C8H5ClN2
Melting Point:-
Smiles Code:ClC1=C2C=CC=CC2=NC=N1
Density:
Catalog Number:CM114974
Molecular Weight:164.59
Boiling Point:281.0±13.0°C at 760 mmHg
MDL No:MFCD00228682
Storage:Keep in inert atmosphere, store at 2-8°C.

Category Infos

Quinazolines
Quinazolines belong to heterocyclic chemistry, also known as 1,3-naphthalenes. The backbone consists of two six-membered aromatic rings fused to each other, with two nitrogen atoms at positions 1 and 3 on the backbone. The presence of these two nitrogen atoms in quinazoline increases its importance in pharmaceutical and biological reactions. Quinazolines and their derivatives are among the most important heterocyclic compounds due to their diverse chemical reactivity and important range of biological activities.

Column Infos

Bexotegrast
Pliant announced positive safety and exploratory efficacy data from the INTEGRIS-PSC Phase 2a trial of Bexotegrast (PLN-74809) 320 mg in patients with primary sclerosing cholangitis and suspected liver ibrosis. PLN-74809 is an oral small-molecule dual-selective inhibitor of αvβ6 and αvβ1 integrins for the treatment of IPF and PSC. While present at very low levels in healthy tissues, these integrins are upregulated in the lungs of IPF patients and the bile ducts of PSC patients where they activate TGF-β, a key driver of the fibrotic process. Blocking these integrins is designed to stop TGF-β activation, potentially halting the growth of scar tissue.